| Autor: |
Tripp, Francisco, Báez, Enrique, Ávila, Elsa, Baltazar, Severiano, Garcés, Oscar, Reyes, Gustavo, Batista, Benjamín, Zaragoza, Alva, Vela-Ojeda, Jorge, Villela, Luis |
| Zdroj: |
Blood; November 2007, Vol. 110 Issue: 11 p4489-4489, 1p |
| Abstrakt: |
Introduction: Patients with aggressive NHL may respond to treatment, but 4-year DFS is < 40%. Rituximab has shown activity as monotherapy in patients even in refractory or relapsing post-MOT patients. Besides, preliminary results from maintenance therapy studies are promising. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
